US 9,077,964 · Application 11/608,776 · Granted Jul 7, 2015
US 9,077,964
Systems and methods for error resilience and random access in video communication systems
Estimated expiration
May 13, 2031
4y 248d remaining
Earliest effective filing
Dec 8, 2006
+ 20 years
Dec 8, 2026
PTA +1617d
May 13, 2031
No TD
—
Final
May 13, 2031
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- December 8, 2006
- Earliest effective filing
- December 8, 2006
- Issue date
- July 7, 2015
- PTA
- +1617 days
- Base expiry (before PTA)
- December 8, 2026
December 8, 2006 + 20 years = December 8, 2026 + 1617 PTA days = May 13, 2031
- PRO60/748,437 — Provisional — not used for base term
- PRO60/778,760 — Provisional — not used for base term
- PRO60/787,043 — Provisional — not used for base term
- PRO60/787,031 — Provisional — not used for base term
- PRO60/829,618 — Provisional — not used for base term
- PRO60/862,510 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 11/608,776 · US 9,077,964
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,077,964: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9077964Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.